Recent scientific and clinical breakthroughs in gene therapy offer hope to patients who live with cancer, retinal disease, hemophilia, neurodegenerative conditions, and other diseases.
Delivering on the promise of therapeutic antibodies requires policies that not only encourage investment in research and development but also ensure these therapies will be accessible to patients.
Health IT Now and the Bipartisan Policy Center along with more than 50 work group members, have outlined a focused and streamlined oversight framework for the federal government’s role in health IT and digital health. Transitioning to this framework will require both regulatory and legislative changes that we encourage stakeholders and policymakers to support as quickly as possible.
Recommendations for the future role of government in health IT and digital health and a discussion on how to support higher quality patient-centered care.
Join us to examine cybersecurity risks associated with medical device technology and the strategies and policies that can help address such risks.
Improving Patient Safety and Information Technology Calls for Greater Leadership, Collaboration, and a Systems-Based Approach
BPC’s new report outlines recommendations for improving health IT’s role in providing safer care for patients while promoting innovation.
The bigger concern is the fact that it takes more than ten years and $2 billion to develop a new drug from a molecule to a medicine.